RxSight Q1 Revenue Miss, Guidance Cut Raise Growth Concerns, BofA Says
In This Article:
RxSight's (RXST) Q1 revenue shortfall and lower 2025 guidance raise concerns about slowing growth an
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.